Highlights • Stented radical cystectomies had higher major complications ( P = 0.04); • Stentless radical cystectomy was noninferior in UIAS rate; • Stentless radical cystectomy was noninferior in UIAL rate;…
Abstract Prostate cancer is the second most diagnosed cancer and the fifth leading cause of cancer death among men worldwide. In the 1980s, the development and implementation of Prostate-Specific Antigen…
Abstract Prostate specific antigen (PSA) has transformed the diagnosis and treatment of prostate cancer by enabling early detection at global scale. Due to expression in both benign and malignant cells,…
Highlights • Family history of prostate cancer is an important risk factor of being diagnosed with the disease, even in the setting of low PSA. • Black men are at…
Highlights • Randomized trials show PSA screening decreases prostate cancer-mortality. • Adjunct tests and focus on high-risk patients will improve prostate cancer screening. • A closer look at divergence in…
Highlights • Prostate specific antigen is a proven screening test that has reduced prostate cancer mortality. • A desire to improve the positive and negative predictive values of PSA has…
Abstract Prostate cancer (PCa) screening has evolved beyond PSA and digital rectal exam to include multiparametric prostate MRI (mpMRI). Incorporating this advanced imaging tool has further limited the well-established problem…
Highlights • There is still uncertainty about PI-RADS 3 lesions. • Machine learning (ML) models are effective in biopsy decision making in PI-RADS 3 lesions. • Parameters such as SII,…
Highlights • GGT for patients with PCa increased from 21 in Q2 2015 to 1,509 in Q3 2020. • Proportion of GGT ordered by urologists increased from 0% in 2015…
Highlights • Our study explores the efficacy of prostate ablation, both whole-gland and partial-gland ablation, as an emerging treatment for localized prostate cancer, emphasizing its potential in reducing quality of…
